August 11, 2026 — This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising. Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company developing novel serotonergic agonists (“NSAs”), announced that CEO Michael Halstead will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference, taking place Aug.
August 11, 2026 — AZIO AI Holdings (NASDAQ: AZIO) announced its placement in an AINewsWire (“AINW”) editorial examining how surging artificial intelligence adoption is driving increased demand for power, data-center capacity, high-speed connectivity and next-generation GPU systems. The editorial, “As AI Races Ahead, the Real Battle Is Over Power and Infrastructure,” highlights AZIO’s strategy of building an integrated infrastructure platform spanning digital power, data-center development, enterprise fiber and GPU deployment, including its Master Services Agreement with AT&T, power and hosting agreement and recently announced letter of intent (“LOI”) with Power Champion.
August 11, 2026 — Earth Science Tech, a growing healthcare holding company, recently reported its Q1 2027 financial results, with key highlights including $9. 0 million in revenue, $6.
August 11, 2026 — A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) a global smart retail technology company, announced a follow-on purchase order from Sapir Group for an additional 4,000 Cust2Mate smart shopping carts, increasing the Israeli supermarket group’s total commitment to 7,000 carts and bringing the total value of its orders to approximately $84 million over the life of the agreements.
August 11, 2026 — AOM Capital announced the completion of a $5. 1 million financing for a therapeutics company in connection with its acquisition of a pharmaceutical drug asset.
August 10, 2026 — This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.
August 10, 2026 — Greenland Mines (NASDAQ: GRML) is pursuing a diversified critical minerals strategy focused on Greenland as demand for resources essential to electric vehicles, renewable energy, semiconductors, advanced computing and defense technologies continues to grow. The company aims to build a portfolio of projects spanning multiple strategically important commodities rather than relying on a single mineral, while also pursuing acquisitions and partnerships to expand its position.
August 10, 2026 — Forward Industries (NASDAQ: FWDI) expanded its Solana treasury by more than 500,000 SOL during fiscal Q3 2026 at an average purchase price of approximately $79 per SOL, bringing its holdings to 7. 55 million SOL as of June 30.
August 10, 2026 — EquiDeFi Prometheus AI SPV, LLC has partnered with EquiDeFi, Ltd. to launch a private offering providing accredited investors with indirect exposure to Series B preferred shares of a major pre-IPO artificial intelligence company co-founded by Jeff Bezos and Vikram Bajaj.
August 10, 2026 — SKYX Platforms (NASDAQ: SKYX) announced that it will host its second-quarter 2026 earnings conference call on Wednesday, Aug. 12, 2026, at 4:30 p.
August 10, 2026 — he International Energy Agency (“IEA”) projects that global data-center electricity consumption will more than double to roughly 945 terawatt-hours by 2030, with AI cited as the most important driver of that growth. As a result, investor attention is widening from AI software and chip design toward the “picks and shovels” layer of the industry: power, hyperscale data-center capacity, high-speed connectivity and next-generation GPU systems.
August 10, 2026 — AZIO AI Holdings (NASDAQ: AZIO) is featured in an AINewsWire editorial titled “As AI Races Ahead, the Real Battle Is Over Power and Infrastructure,” examining how accelerating artificial intelligence adoption is driving demand for the physical infrastructure required to support AI computing. The editorial highlights AZIO AI integrated infrastructure strategy, including its planned 500-megawatt Texas AI data-center campus, Master Services Agreement with AT&T for enterprise fiber connectivity and power purchase and AI infrastructure hosting agreement with Power Champion Investment Limited.
August 10, 2026 — This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.
August 10, 2026 — NanoViricides, Inc. (NYSE American: NNVC) announced that it has received regulatory approval from the local regulatory agency “ACOREP” in the Democratic Republic of Congo (“DRC”) to begin a Phase II clinical trial of NV-387 Oral Gummies as a treatment for the current Bundibugyo ebolavirus outbreak and other Ebola viruses.
August 10, 2026 — AINewsWire Editorial Coverage: Artificial intelligence adoption is accelerating faster than the physical world can keep up with it. The International Energy Agency (“IEA”) projects that global data-center electricity consumption will more than double to roughly 945 terawatt-hours by 2030, with AI cited as the most important driver of that growth.
August 10, 2026 — The growing importance of artificial intelligence and digital technology has created a new challenge in modern warfare. Data centers, which were once seen mainly as business facilities that stored information and supported online services, are now becoming strategic targets during conflicts.
August 10, 2026 — Producers of refined copper in China have resorted to using scrap metal for their operations as the availability of copper concentrate feedstocks tightens. Because of limited concentrate availability, processing charges have dropped even more into negative territory.
August 10, 2026 — Scientists at the University of Virginia have discovered that deadly brain tumors may be more susceptible to focused ultrasound than previously thought. Research conducted at the university’s Focused Ultrasound Cancer Immunotherapy Center found that cancer drugs delivered via sound waves could be more effective in treating gliomas than conventional brain cancer treatments.
August 10, 2026 — Disseminated on behalf of Lahontan Gold Corp. (TSX.
August 10, 2026 — Telomir Pharmaceuticals (NASDAQ: TELO) announced the peer-reviewed publication of preclinical data showing Telomir-Zn suppressed tumor growth in prostate and triple-negative breast cancer (“TNBC”) models through selective modulation of intracellular iron and copper. Published in the Journal of Oncology Research and Therapy, the study showed Telomir-Zn inhibited histone demethylases by depleting intracellular iron, selectively killed iron-dependent TNBC cells while sparing normal cells at concentrations more than 50-fold higher and reactivated tumor-suppressor genes in a prostate cancer model.
